← Back to Search

Iron Supplement

Liquid Iron Supplement (Blood Builder ®) for Iron Deficiency

N/A
Waitlist Available
Research Sponsored by Applied Science & Performance Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0, week 4, and week 8
Awards & highlights

Study Summary

This trial is testing a new low-dose iron supplement to see if it is safe and effective in restoring iron levels without causing constipation among healthy premenopausal women with iron deficiency.

Eligible Conditions
  • Iron Deficiency

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0, week 4, and week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0, week 4, and week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Complete Blood Count
High Sensitivity C-Reactive Protein (hs-CRP)
Serum Ferritin
+3 more
Secondary outcome measures
Abbreviated Profile of Mood States
Adverse Events
Cathartics
+2 more
Other outcome measures
Body Composition via Body Fat Percentage
Bone Mineral Density

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Blood Builder TreatmentExperimental Treatment1 Intervention
Daily dose (10 mL) of liquid iron supplement (Blood Builder®) formulation to be ingested on an empty stomach no sooner than 3 hours after consuming a meal.
Group II: PlaceboPlacebo Group1 Intervention
Daily dose (10 mL) of a visually identical liquid placebo supplement to be ingested on an empty stomach no sooner than 3 hours after consuming a meal.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Liquid Iron Supplement (Blood Builder ®)
2022
N/A
~100

Find a Location

Who is running the clinical trial?

Applied Science & Performance InstituteLead Sponsor
11 Previous Clinical Trials
584 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Alabama
How old are they?
18 - 65
What site did they apply to?
The Applied Science and Performance Institute
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels
2022. "Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05257343.
~30 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top